Cargando…
Ocular iontophoresis of EGP-437 (dexamethasone phosphate) in dry eye patients: results of a randomized clinical trial
PURPOSE: To assess safety and efficacy of EGP-437 (dexamethasone phosphate 40 mg/mL [DP]) in dry eye patients. METHODS: The study employed a prospective, single-center, double-masked design utilizing a Controlled Adverse Environment (CAE). Patients (n = 103) with confirmed signs and symptoms of dry...
Autores principales: | Patane, Michael A, Cohen, Amy, From, Stephen, Torkildsen, Gail, Welch, Donna, Ousler, George W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104791/ https://www.ncbi.nlm.nih.gov/pubmed/21629568 http://dx.doi.org/10.2147/OPTH.S19349 |
Ejemplares similares
-
The EGP at five years.
por: Dahl, Richard
Publicado: (2003) -
The IMPACT study: a prospective evaluation of the effects of cyclosporine ophthalmic emulsion 0.05% on ocular surface staining and visual performance in patients with dry eye
por: Stonecipher, Karl G, et al.
Publicado: (2016) -
Exacerbation of signs and symptoms of allergic conjunctivitis by a controlled adverse environment challenge in subjects with a history of dry eye and ocular allergy
por: Gomes, Paulo J, et al.
Publicado: (2013) -
Safety and efficacy of MIM-D3 ophthalmic solutions in a randomized, placebo-controlled Phase 2 clinical trial in patients with dry eye
por: Meerovitch, Karen, et al.
Publicado: (2013) -
Automated grading system for evaluation of ocular redness associated with dry eye
por: Rodriguez, John D, et al.
Publicado: (2013)